Introduction {#s0005}
============

Milia are superficial keratinous cysts, clinically seen as pearly white, dome-shaped lesions 1--2 mm in diameter. Histologically, they are seen as miniature infundibular cysts with walls of stratified squamous epithelium containing a granular cell layer. Milia may be classified as primary or secondary, depending on how the lesions originated. Primary milia are thought to form spontaneously from the sebaceous collar of vellus hairs; secondary milia are derived from eccrine ducts and may be disease-associated, medication-associated, or caused by trauma ([@b0020]).

Subepidermal blistering diseases, such as the hereditary forms of epidermolysis bullosa, epidermolysis bullosa acquisita (EBA), bullous pemphigoid (BP), bullous lichen planus, porphyria cutanea tarda, variegate porphyria, and pseudoporphyria, are associated with the formation of secondary milia in areas of previous blistering. In porphyria, bullae are known to be fragile and heal with scarring and milia. In other blistering disorders, however, multiple milia are less known to occur. In addition, multiple milia may also be observed in skin areas without evidence of blistering ([@b0005]). Whether the formation of milia in seemingly unaffected skin is a criterion in diagnosing subepidermal blistering diseases remains questionable.

We conducted this study to search the literature for cases of blistering diseases with multiple eruptive milia formation, especially in areas of the skin where there is no evidence of blistering or trauma, and review the interpretations of their pathogenesis. We focused our search on blistering disorders, excluding porphyria to highlight the occurrence of extensive multiple milia formation in blistering disorders of autoimmune, inflammatory, or genetic origin (see [Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}, [Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"}).Fig. 1Methodology.Fig. 2Multiple milia in two female patients with epidermolysis bullosa acquisita.Fig. 3Multiple milia in a female patient with bullous pemphigoid.Fig. 4Multiple milia in a female patient with recessive dystrophic epidermolysis bullosa.

Methods {#s0010}
=======

We performed a literature search on PubMed for the terms "multiple eruptive milia", "multiple milia", and "reactive milia". Another search for "bullous disease", "blistering disease", "pemphigoid", "epidermolysis", and "lichen planus" was also conducted. The conjunction of these two queries was then searched, yielding 23 results. Only reports published in English and reports with autoimmune, inflammatory, or genetic blistering disorders were included.

Results and discussion {#s0015}
======================

Few studies have investigated the origin of milia, especially the differences between primary and secondary milia. Milia may be a feature of many different dermatological diseases, as previously described ([@b0050]).

We found several cases reporting the formation of multiple milia in blistering diseases ([Table 1](#t0005){ref-type="table"}). The underlying blistering disease present in these cases varies, ranging from hereditary forms of EB to autoimmune blistering diseases. In all cases but one, multiple milia appeared on sites of previous blistering. [@b0005] reported a case of dominant dystrophic EB in a 3-month-old girl where milia were observed before any report of blistering. Although blisters could have appeared in the prenatal or neonatal period, multiple milia appeared to be the only initial sign of dominant dystrophic epidermolysis bullosa in this patient. This presents an important opportunity for dermatologists and geneticists in the future who are presented with a similar case, as proper genetic counseling and advise should be given to expectant parents who have a family history of the disease.Table 1Cases of multiple secondary milia formation in subepidermal blistering diseases.AuthorsYearAge/SexBlistering disorder presentAutoantibodies presentMilia on sites of previous blistersMilia on unaffected skinMayuzumi et al.20064/MChildhood EBANC1 and 2 of type VII collagen+--Tsuruta et al.201355/FBPAnti-BP180+--Uchida et al.201462/MBPAnti-BP180+--Vink and Starink201479/FBullous acral lichen sclerosus--+--Sonthalia et al.20165/MLinear lichen planus pigmentosus--+--Akasaka et al.20173 months/FDominant dystrophic epidermolysis bullosa----+ (before visible blistering)Ding et al.201725/MBPAnti-Dsg1Anti-Dsg3Anti-BP180+--Kumudhini et al.201835/FBPAnti-BP180Anti-BP230+--Amin et al.201980/MBPAnti-BP180+--Beiu et al.201954/MEBA--+--[^1]

Milia are also known to develop in EBA ([@b0035]) and mucous membrane pemphigoid, but are uncommon in BP ([@b0010]). Because of this, many experts in EBA consider milia formation a possible diagnostic criterion and a differentiating factor from other blistering diseases. Because the diagnosis of blistering diseases may be challenging, especially in resource-limited settings, clear criteria that will help in diagnosis are important. Thus, despite the common occurrence of milia in EB and EBA, reports of milia in mucous membrane pemphigoid and BP could make milia formation a weaker differential criterion for the entire pemphigoid group ([@b0050]).

In the reported cases of BP with multiple milia, different autoantibodies were detected, including those seen in pemphigus, and [@b0025] reported a case of BP with high levels of anti-desmoglein 1 and anti-desmoglein 3, along with high anti-BP180 titers. In [@b0030], milia developed in a patient with high autoantibody titers of anti-BP180; this patient required adjuvant treatment with cyclophosphamide. Similarly, [@b0055] reported patients with BP who had high autoantibody titers that seemed to parallel high disease activity and that the resulting milia may be related to the intensity of inflammation along the dermo-epidermal junction. Thus it might be valuable to prospectively study high titer and/or refractory pemphigoid diseases to determine whether there is a relationship to milia formation.

Immunological predisposition is also thought to play a role in milia formation in patients with BP. [@b0015] studied human leukocyte antigen associations in 74 patients with BP and compared their profiles with those of unrelated control subjects. The presence of the human leukocyte antigen DQ6 was linked with milia formation in both men and women ([@b0015]). Milia formation in BP may have also resulted from the aberrant interaction between the hemidesmosomes and the extracellular matrix components beneath the hemidesmosomes with IgG autoantibodies to LAD-1 and/or the recombinant protein of the BP180 C-terminal domain ([@b0055]). The pathophysiology of milia formation in patients with BP remains unknown; thus, investigating this could present an ancillary approach to managing patients with BP after recovery from bullous lesions, thereby affecting their quality of life.

In blistering diseases related to lichenoid processes, the ongoing intense inflammation leading to blister formation could result in the occurrence of milia. Patients with linear lichen planus pigmentosus ([@b0045]) and bullous acral lichen sclerosus ([@b0060]) were reported to have milia after healing of subepidermal blisters. Future studies could perhaps investigate whether early or aggressive intervention to control inflammation can also prevent milia formation later.

The treatment of milia from bullous disorders is not different from that of primary milia. Because milia are benign cysts, they present more of a cosmetic problem for the patient. Spontaneous regression within several months has been seen. However, for patients who insist on an intervention, options may include excision and curettage, electrodessication, dermabrasion, cryotherapy, topical tretinoin, photodynamic therapy, Er:YAG or CO~2~ laser, and oral minocycline ([@b0040]). As of this writing, no comparative studies have evaluated the efficacy or superiority of any of these methods in the treatment of multiple milia.

Although the exact incidence of milia in blistering diseases is unknown, it may be more common than previously thought. Patients with blistering diseases are faced with an overwhelming burden of the disease itself, further complicated by the associated sequelae of both the disease and the treatment. Dermatologists treating these patients must always aim to provide a comprehensive and thoughtful explanation of the disease and its complications. Although they may seem inconsequential and are more of a cosmetic concern, patients must be made aware of the possibility of developing multiple milia in any phase of their disease.

Conclusion {#s0020}
==========

Milia are benign keratinous cysts that result from the regeneration process of sweat glands or hair follicles. The exact etiology of multiple milia formation in subepidermal blistering disorders is still unknown, but an interplay of immunologic predisposition and atypical interactions between hemidesmosomal components and the extracellular matrix is suggested. Multiple milia are not exclusively seen in just one blistering disease; thus, clinicians must remember that the presence of these lesions does not definitively diagnose any specific blistering disorder. Further studies into the pathophysiology of milia formation in blistering diseases are needed to understand its mechanism and to provide the best approaches in improving the quality of life of patients afflicted with these diseases.
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[^1]: BP, bullous pemphigoid; EBA, epidermolysis bullosa acquisita; Dsg, desmoglein; F, female; M, male.
